Delivery of general hospital medicinal products for UMBAL Dr. Georgi Stranski EAD - Pleven
Originaltitel der Bekanntmachung
Bulgaria – Pharmaceutical products – Доставка на общоболнични лекарствени продукти за нуждите на „УМБАЛ Д-р Георги Странски” ЕАД – гр. Плевен
Opportunity Score
Warum diese Bewertung?
Chance
70 / 100
Komplexität
65 / 100
Risikofaktoren
Notice type is 'cn-standard' (contract award) subtype 16, but the procedure is flagged as a DPS with restricted procedu...
Structured data indicates EU-funded (isEuFunded: true), but XML notice shows 'FundingProgramCode: no-eu-funds'. This af...
Restricted procedure — pre-qualification required
Tiefe Portfolioanalyse
Verwendet:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Überblick
Moderate opportunityWichtige Fakten
- BGN 44.2M estimated value
- Dynamic Purchasing System (DPS)
- Supplies contract
- 1 lot
- Duration 36 MONTH
- Supply of 655 hospital pharmaceutical products (general medicines) to UMBAL Dr. Georgi Stranski EAD in Pleven, Bulgaria
- Deliveries made upon written requests over a 36-month period
Vollständige Zusammenfassung anzeigen
This tender by University Multi-Profile Hospital for Active Treatment 'Dr. Georgi Stranski' EAD - Pleven (Bulgaria) seeks a supplier for the delivery of 655 general hospital pharmaceutical products via a Dynamic Purchasing System (DPS) under a restricted procedure. The estimated total value is BGN 44,239,186.49 (approx. €22.6M) for a 36-month period. Award is based solely on lowest price. The notice is a contract award (cn-standard) with subtype 16, but the DPS nature and long deadline (2028) raise procedural ambiguities. The structured data indicates EU funding, but the XML notice states no EU funds. Only notice-level data was analyzed; procurement documents were not reviewed.
Risiken
Notice type is 'cn-standard' (contract award) subtype 16, but the procedure is flagged as a DPS with restricted procedu...
Structured data indicates EU-funded (isEuFunded: true), but XML notice shows 'FundingProgramCode: no-eu-funds'. This af...
Restricted procedure — pre-qualification required
Analyse kann unvollständig sein
Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.
Wichtige Anforderungen
Technical
- Tenderer must be registered as a trader with the right to wholesale medicinal products
- Must hold a wholesale distribution authorization from the Bulgarian Drug Agency (IAL) or equivalent EU authority
- If producer, must hold a manufacturing authorization; otherwise, an authorization from the manufacturer
Anforderungen können unvollständig sein.
Zuschlagskriterien
Lot 1
Auftraggeber
Ort
гр. Плевен, BGR
Auftraggeberprofil
Kennung
114532352
Tätigkeit
Health
Lose (1)
LOT-0001
Delivery of general hospital medicinal products for UMBAL Dr. Georgi Stranski EAD - Pleven
Single lot covering the supply of 655 different hospital pharmaceutical products, delivered as needed per written requests over 36 months. The lot is part of a DPS with restricted procedure. Performance location: Pleven, Bulgaria (BG314).
BGN 44.2M
Geschätzter Wert
Ort
Dauer
Kategorie
Zuschlagskriterien
Frist
Zuschlagsdetails
На първо място се класира участникът, предложил най-ниска цена. Останалите оферти заемат места в класирането по низходящ ред
Hinweis zum Wert
Originale TED-Daten anzeigen
Originaler Los-Titel
Доставка на общоболнични лекарствени продукти за нуждите на „УМБАЛ Д-р Георги Странски” ЕАД – гр. Плевен
Originale TED-Beschreibung
Процедура по реда на Закона за обществените поръчки за доставка на общоболнични лекарствени продукти по предварителни писмени заявки за нуждите на лечебния процес в „УМБАЛ Д-р Георги Странски” ЕАД – Плевен, по смисъла на Закона за лекарствените продукти в хуманната медицина, съгласно техническата спецификация и условията на настоящата документация. Обектът на обществената поръчка, включва 655 артикула.
Vergabedetails
- Veröffentlichungsdatum
- 17 Feb 2025
- Sprachen
- Bulgarian
Referenzmetadaten
- Rechtsgrundlage
- 32014L0024
Referenz-IDs
- Ausschreibungs-ID
- 107390-2025
Dokumente (1)
Ähnliche Ausschreibungen
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Belgium – Pharmaceutical products – Antimycotica
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Denmark – Pharmaceutical products – Amgros 2027 1.1170.a
Opportunity Score
Warum diese Bewertung?
Chance
70 / 100
Komplexität
65 / 100
Risikofaktoren
Notice type is 'cn-standard' (contract award) subtype 16, but the procedure is flagged as a DPS with restricted procedu...
Structured data indicates EU-funded (isEuFunded: true), but XML notice shows 'FundingProgramCode: no-eu-funds'. This af...
Restricted procedure — pre-qualification required
Tiefe Portfolioanalyse
Verwendet:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications